Benchmark Animal Health

Benchmark Animal Health is owned by Benchmark Holdings.

Benchmark Holdings is a company listed under the stock ticker BMK (GB).

Benchmark Holdings has a direct presence in 2 countries.

They are in:

• Biotechnology67%
• Pharmaceuticals33%

View the org chart displaying its 5 main executives

Most searched biographies at Benchmark Animal Health

• John Marshall, Managing Director
• Mark Todman, Head of Business Development
• Lucy Baines, Head of Programme Management

Popular executive movements at Benchmark Holdings

• Susan Searle, Non-Executive Director, has left the company  (posted on December 13 2023).
• Jonathan Esfandi has joined the company as Director  (posted on November 29 2023).

Create your alert
to follow the executive moves at Benchmark Animal Health.

Benchmark Holdings has 1,861 competitors including Pfizer (United States (USA)), Sanofi (France) and Johnson & Johnson (United States (USA)).

Popular M&A news in Pharmaceuticals

• MedMen has filed for bankruptcy protection  (posted on April 28 2024).
• AstraZeneca has announced the acquisition of Fusion Pharma  (posted on March 23 2024).
• AstraZeneca has announced the acquisition of Amolyt Pharma  (posted on March 19 2024).

Popular contacts in Pharmaceuticals

• Jean-Frédéric Paulsen - Executive Chairman of the Board at Ferring Pharmaceuticals
• Thierry Abribat - Chief Executive Officer at Amolyt Pharma
• Emma Walmsley - Chief Executive Officer and Director at GSK

Learn more about the Pharmaceuticals industry >

Press releases by Benchmark Animal Health

Social media about Benchmark Animal Health

• Benchmark Animal Health on Wikipedia, Google News & Yahoo Finance
• Benchmark Animal Health on LinkedIn, Twitter & YouTube

Contact by email its executives including John Marshall

Call Benchmark Animal Health at +44 114...

View the org chart

Register to receive your alert

Report an error